

<!DOCTYPE html>
<html lang="en-GB">
    <head>
        <meta charset="utf-8" />
        <meta content="IE=edge,chrome=1" name="X-UA-Compatible" />
        <meta content="width=device-width, initial-scale=1, maximum-scale=1" name="viewport" />
        <title>Cost-saving guidance | Into practice | What we do | About | NICE</title>
        <link href="//fonts.googleapis.com/css?family=Lato:200normal,200italic,300normal,300italic,400normal,400italic,700normal,700italic,900normal,900italic" rel="stylesheet" type="text/css" />

<link href="/css/app.css" rel="stylesheet" type="text/css" />

<!--[if lt IE 9]>
<script src="//cdn.nice.org.uk/V2/Scripts/html5shiv/html5shiv.js" type="text/javascript"></script>
<![endif]-->
<script src="https://www.nice.org.uk/Themes/NICE.Bootstrap/scripts/jquery/jquery-1.12.4.min.js" type="text/javascript"></script>
<script src="https://www.nice.org.uk/Themes/NICE.Bootstrap/scripts/head.combined-v1.10.6834.0.js" type="text/javascript"></script>






  <meta charset="utf-8" />
  <meta name="X-UA-Compatible" content="IE=edge,chrome=1" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta property="og:locale" content="en_GB" />
  <meta name="x-country" content="gb" />
  <meta name="DC.Title" content="Cost-saving guidance | Into practice | What we do | About | NICE" />
  <meta property="og:title" content="Cost-saving guidance" />
  <meta name="twitter:title" content="Cost-saving guidance" />
  <meta name="msapplication-TileColor" content="#f6f6f6" />
  <meta name="msapplication-TileImage" content="//cdn.nice.org.uk/V3/Content/nice/favicon-144.png" />
  <meta name="DC.Publisher" content="NICE" />
  <meta name="DC.Rights.Copyright" content="All content on this site is NICE copyright unless otherwise stated. You can download material for private research, study or in-house use only. Do not distribute or publish any material from this site without first obtaining NICE's permission. Where Crown copyright applies, see the Office of Public Sector Information (formerly HMSO) website for information." />
  <meta name="DC.Language" scheme="DCTERMS.ISO639-2T" content="eng" />
  <meta name="DC.Subject" scheme="eGMS.IPSV" content="Health, well-being and care" />
  <meta name="eGMS.accessibility" scheme="eGMS.WCAG10" content="Double-A" />
  <meta property="og:site_name" content="NICE" />
  <meta name="twitter:site" content="@NICEcomms" />
  <meta name="twitter:creator" content="@NICEcomms" />
  <meta name="twitter:card" content="summary" />
  <meta property="og:url" content="https://www.nice.org.uk/about/what-we-do/into-practice/cost-saving-guidance" />
  <meta property="og:type" content="article" />
  <meta property="article:author" content="https://www.facebook.com/NationalInstituteforHealthandCareExcellence" />
  <meta name="cid" content="26205" />
  <meta name="DC.Issued" scheme="DCTERMS.W3CDTF" content="2017-11-24" />
  <meta name="DC.Modified" scheme="DCTERMS.W3CDTF" content="2017-11-24" />
  <meta name="DC.Type" scheme="NICE.Publication.Types" content="CorporatePage"/>
  <meta name="description" content="NICE guidance that could generate cost savings. " />
  <meta property="og:description" content="NICE guidance that could generate cost savings. " />
  <meta name="twitter:description" content="NICE guidance that could generate cost savings. " />



        <link rel="shortcut icon" href="//cdn.nice.org.uk/V3/Content/nice/favicon.ico" />
        <link rel="apple-touch-icon-precomposed" href="//cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
        <link rel="apple-touch-icon" href="//cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
        <link rel="apple-touch-icon-precomposed" sizes="120x120" href="//cdn.nice.org.uk/V3/Content/nice/favicon-120.png">
        <link rel="apple-touch-icon" sizes="120x120" href="//cdn.nice.org.uk/V3/Content/nice/favicon-120.png">
        <link rel="apple-touch-icon-precomposed" sizes="152x152" href="//cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
        <link rel="apple-touch-icon" sizes="152x152" href="//cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
            <link rel="canonical" href="https://www.nice.org.uk/about/what-we-do/into-practice/cost-saving-guidance" />
        <!--[if IE 6]><script>var ieVersion = 6;</script><![endif]-->
        <!--[if IE 7]><script>var ieVersion = 7;</script><![endif]-->
        <!--[if IE 8]><script>var ieVersion = 8;</script><![endif]-->


<script>     (function(h,o,t,j,a,r){         h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};         h._hjSettings={hjid:119167,hjsv:5};         a=o.getElementsByTagName('head')[0];         r=o.createElement('script');r.async=1;         r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;         a.appendChild(r);     })(window,document,'//static.hotjar.com/c/hotjar-','.js?sv='); </script><meta name="theme-color" content="#333"> <!-- Start Visual Website Optimizer Asynchronous Code -->         <script type='text/javascript'>             var _vwo_code=(function(){             var account_id=257258, _vis_opt_url = window._vis_opt_url || document.URL,             settings_tolerance=2000,             library_tolerance=2500,             use_existing_jquery=false,             /* DO NOT EDIT BELOW THIS LINE */             f=false,d=document;return{use_existing_jquery:function(){return use_existing_jquery;},library_tolerance:function(){return library_tolerance;},finish:function(){if(!f){f=true;var a=d.getElementById('_vis_opt_path_hides');if(a)a.parentNode.removeChild(a);}},finished:function(){return f;},load:function(a){var b=d.createElement('script');b.src=a;b.type='text/javascript';b.innerText;b.onerror=function(){_vwo_code.finish();};d.getElementsByTagName('head')[0].appendChild(b);},init:function(){settings_timer=setTimeout('_vwo_code.finish()',settings_tolerance);var a=d.createElement('style'),b='body{opacity:0 !important;filter:alpha(opacity=0) !important;background:none !important;}',h=d.getElementsByTagName('head')[0];a.setAttribute('id','_vis_opt_path_hides');a.setAttribute('type','text/css');if(a.styleSheet)a.styleSheet.cssText=b;else a.appendChild(d.createTextNode(b));h.appendChild(a);this.load('//dev.visualwebsiteoptimizer.com/j.php?a='+account_id+'&u='+encodeURIComponent(_vis_opt_url)+'&r='+Math.random());return settings_timer;}};}());_vwo_settings_timer=_vwo_code.init();         </script>         <!-- End Visual Website Optimizer Asynchronous Code --><link href="https://www.nice.org.uk/Media/Default/css/default.css" rel="stylesheet" type="text/css" /><script src="https://www.nice.org.uk/Media/Default/js/default.js" type="text/javascript"></script>            </head>


<body data-spy="scroll" data-target=".aside-primary" class=" " >
<!-- Google Tag Manager -->
    <script src="/setgtmdatalayer"></script>
    <noscript>
        <iframe src="//www.googletagmanager.com/ns.html?id=GTM-M55QTQ"
                height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                    new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
                    j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
                        '//www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-M55QTQ');</script>
<!-- End Google Tag Manager -->


<div class="nice-tophat">
    <div class="nice-services blackbar"></div>
    <div class="searchbar"></div>
</div>

<div id="printpane"></div>
    <header class="page-header  ">
<div class="zone zone-breadcrumb">

<div class="widget-breadcrumb widget-sub-menu-widget widget">
    <div class="widget-content">

<div class="container">

<ul class="breadcrumb">
    <li><a href="/" data-track="mainbreadcrumb">Home</a><i class="divider icon-nice-chevron-right"></i></li>

    <li><a href="/about" data-track="mainbreadcrumb">About</a> <i class="divider icon-nice-chevron-right"></i></li>
    <li><a href="/about/what-we-do" data-track="mainbreadcrumb">What we do</a> <i class="divider icon-nice-chevron-right"></i></li>
        <li class="active"><a href="/about/what-we-do/into-practice" data-track="mainbreadcrumb">Into practice</a></li>
</ul>
    <h1>Cost-saving guidance</h1>


</div>
    </div>
  </div></div>            </header>
<div id="toTop"><i aria-hidden="true" class="icon-nice-chevron-up"></i></div>
<div class="layout ">
    <div class="">
                        <div class="zone zone-content"><div class="page-content corporate-content">
  <div class="row">
<div class="span8">
<p class="lead">We've identified NICE guidance that could generate cost savings.&nbsp;</p>
<p>In some cases, implementing guidance will free up resources and capacity that can be used for other services. This results in improved productivity rather than delivering actual cash savings.</p>
<p>Our resource impact reports and templates (linked in the table below) allow you to more accurately estimate savings for your local setting.</p>
<p></p>
</div>
<div class="span4">
<div class="panel panel-default">
<div class="panel panel-heading">
<h3>Find out more</h3>
</div>
<div class="panel panel-body">
<p><a href="/about/what-we-do/into-practice/resource-impact-assessment">How do we assess the resource impact of guidance?</a></p>
</div>
</div>
</div>
</div>
<table class="table table-striped table-bordered" style="width: 100%;"><colgroup><col width="25%" /> <col width="45%" /> <col width="13%" /> <col width="10%" /> <col width="7%" /> </colgroup>
<tbody>
<tr>
<td style="text-align: center;"><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;"><strong>Guidance</strong></span></span></td>
<td style="text-align: center;"><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;"><strong> Why does this guidance save money?</strong> </span></span></td>
<td style="text-align: center;"><strong><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">How will the guidance save money?&nbsp;</span></span></strong></td>
<td style="text-align: right;">
<p style="text-align: center;"><strong>Estimated saving per 100,000 population (&pound;)</strong></p>
</td>
<td style="text-align: right;">
<p style="text-align: center;"><strong>Estimated saving for England (&pound; million)</strong></p>
</td>
</tr>
<tr height="85">
<td class="xl69" width="197">
<p><a href="/cg95">Chest pain of recent onset: assessment and diagnosis (CG95)</a></p>
</td>
<td class="xl69" width="446">
<p>Savings are anticipated as a result of a shift in diagnostic imaging.</p>
<p>An increase in the number of people receiving CT coronary angiography leads to savings from reduced numbers of people receiving invasive coronary angiography and other diagnostic tests.</p>
</td>
<td>
<p><a class="track-link" href="/guidance/cg95/resources/resource-impact-report-pdf-2726121709" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/cg95/resources/resource-impact-report-pdf-2726121709"> <i class="icon-download"></i> Resource impact report</a></p>
<p><a class="track-link" href="/guidance/cg95/resources/resource-impact-template-excel-2726156701" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/cg95/resources/resource-impact-template-excel-2726156701"> <i class="icon-download"></i> Resource impact template </a></p>
<p><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;"></span></span></p>
</td>
<td width="85" style="text-align: right;"><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">&pound;31,500</span></span></td>
<td width="85" style="text-align: right;">&pound;17.0m<span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;"></span></span></td>
</tr>
<tr height="102">
<td class="xl69" width="197"><a href="/ta369">Ciclosporin for treating dry eye disease that has not improved despite treatment with artificial tears (TA369)</a></td>
<td class="xl67" width="446">
<p>The resource impact assessment indicates that there will be a saving from implementing the guidance due to decreased drug costs and the large eligible population. Savings will be less in earlier years due to lower initial uptake of the technology.</p>
</td>
<td>
<p><a class="track-link" href="/guidance/ta369/resources/resource-impact-report-pdf-2239258573" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/ta369/resources/resource-impact-report-pdf-2239258573"> <i class="icon-download"></i> Resource impact report </a></p>
<p><a class="track-link" href="/guidance/ta369/resources/resource-impact-template-excel-2239257277" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/ta369/resources/resource-impact-template-excel-2239257277"> <i class="icon-download"></i> Resource impact template </a></p>
</td>
<td class="xl72" width="85" style="text-align: right;"><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">&pound;24,400</span></span></td>
<td class="xl72" width="85" style="text-align: right;">&pound;13.1m<span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;"></span></span></td>
</tr>
<tr height="136">
<td class="xl69" width="197"><a href="/dg11">Faecal calprotectin diagnostic tests to differentiate inflammatory bowel disease from irritable bowel syndrome (DG11)</a></td>
<td class="xl69" width="446">It is anticipated that there will be a cost saving from avoiding referrals to secondary care. This should lead to a reduction in capacity requirements and waiting times for endoscopy/colonoscopy/sigmoidoscopy in secondary care services.</td>
<td>
<p><a class="track-link" href="/guidance/dg11/resources/costing-template-excel-145117" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/dg11/resources/costing-template-excel-145117"> <i class="icon-download"></i> Costing template </a></p>
</td>
<td class="xl70" width="85" style="text-align: right;"><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">&pound;20,000</span></span></td>
<td class="xl70" width="85" style="text-align: right;">&pound;11.1m<span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;"></span></span></td>
</tr>
<tr height="136">
<td class="xl69" width="197"><a href="/dg28">Virtual chromoendoscopy to assess colorectal polyps during colonoscopy (DG28)</a></td>
<td class="xl69" width="446">Resource impact work indicates implementation will be cost saving from the avoidance of unnecessary histopathology assessments when assessing colorectal polyps.</td>
<td>
<p><a class="track-link" href="https://www.nice.org.uk/guidance/dg28/resources/resource-impact-report-pdf-4476369709" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="https://www.nice.org.uk/guidance/dg28/resources/resource-impact-report-pdf-4476369709"> <i class="icon-download"></i> Resource impact report </a></p>
<p><a class="track-link" href="https://www.nice.org.uk/guidance/dg28/resources/resource-impact-template-excel-4476371005" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="https://www.nice.org.uk/guidance/dg28/resources/resource-impact-template-excel-4476371005"> <i class="icon-download"></i> Resource impact template </a></p>
</td>
<td class="xl70" width="85" style="text-align: right;">
<p>&pound;18,800</p>
</td>
<td class="xl70" width="85" style="text-align: right;">&pound;10.3m<span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;"></span></span></td>
</tr>
<tr height="68">
<td class="xl69" width="197"><a href="/mtg28">Spectra Optia for automated red blood cell exchange in patients with sickle cell disease (MTG28)</a></td>
<td class="xl69" width="446">Savings for commissioners are expected due to the reduced number of people requiring chelation therapy.</td>
<td>
<p><a class="track-link" href="https://www.nice.org.uk/guidance/mtg28/resources/resource-impact-report-pdf-2366729245" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="https://www.nice.org.uk/guidance/mtg28/resources/resource-impact-report-pdf-2366729245"> <i class="icon-download"></i> Resource impact report </a></p>
<p><a class="track-link" href="/guidance/mtg28/resources/resource-impact-template-excel-2366870509" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/mtg28/resources/resource-impact-template-excel-2366870509"> <i class="icon-download"></i> Resource impact template </a></p>
</td>
<td class="xl72" width="85" style="text-align: right;"><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">&pound;18,100</span></span></td>
<td class="xl72" width="85" style="text-align: right;">&pound;12.9<span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;"></span></span></td>
</tr>
<tr height="136">
<td class="xl69" width="197"><a href="/mtg32">HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography (MTG32)</a></td>
<td class="xl69" width="446">
<p>There may be a significant national saving from the avoidance of &nbsp;unnecessary invasive coronary angiography (ICA) and percutaneous coronary interventions (PCI). The availability of 64-slice CT coronary angiography may be a barrier to realising the savings in full.</p>
<p>There is currently no national tariff for HeartFlow FFRCT and uncertainties around funding flows for provider organisations may be a barrier to implementation of the technology.</p>
<p>Commissioners are encouraged to work with provider organisations to develop a local tariff to establish the use of HeartFlow FFRCT in interventional cardiology service provision.</p>
</td>
<td>
<p><a class="track-link" href="/guidance/mtg32/resources/resource-impact-report-pdf-4363975405" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/mtg32/resources/resource-impact-report-pdf-4363975405"> <i class="icon-download"></i> Resource impact report </a></p>
<p><a class="track-link" href="/guidance/mtg32/resources/resource-impact-template-excel-4363976701" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/mtg32/resources/resource-impact-template-excel-4363976701"> <i class="icon-download"></i> Resource impact template </a></p>
</td>
<td class="xl72" width="85" style="text-align: right;"><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">&pound;16,800</span></span></td>
<td class="xl72" width="85" style="text-align: right;">&pound;9.1m<span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;"></span></span></td>
</tr>
<tr height="136">
<td class="xl69" width="197"><a href="/ng23">Menopause: diagnosis and management (NG23)</a></td>
<td class="xl69" width="446">
<p>The recommendations should result in a decrease in the number of follicle-stimulating hormone tests being received by women aged 45 years or older and because of this a saving of &pound;9.6 million for England is expected.</p>
<p>Some additional costs may result if women change from using oral to transdermal hormone replacement therapy. These costs are estimated as &pound;0.9 million, resulting in an overall saving of around &pound;8.7 million for England.</p>
</td>
<td>
<p><a class="track-link" href="/guidance/ng23/resources/costing-report-pdf-556376653" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/ng23/resources/costing-report-pdf-556376653"> <i class="icon-download"></i> Costing report </a></p>
<p><a class="track-link" href="/guidance/ng23/resources/costing-template-excel-556236685" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/ng23/resources/costing-template-excel-556236685"> <i class="icon-download"></i> Costing template </a></p>
</td>
<td class="xl72" width="85" style="text-align: right;"><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">&pound;16,500</span></span></td>
<td class="xl72" width="85" style="text-align: right;">&pound;8.7m<span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;"></span></span></td>
</tr>
<tr height="92">
<td class="xl69" width="197"><a href="/mtg30"><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">XprEss <g class="gr_ gr_151 gr-alert gr_spell gr_inline_cards gr_run_anim ContextualSpelling ins-del multiReplace" id="151" data-gr-id="151">multi sinus</g> dilation system for treating chronic sinusitis (MTG30)</span></span></a></td>
<td class="xl69" width="446">
<p>There may be savings from reduced inpatient procedures, fewer revision operations being needed, and fewer readmissions following treatment with XprESS. The level of savings depends on how many XprESS procedures are done in an outpatient setting and the device cost of XprESS.</p>
<p>Additional benefits include reducing the number of inpatient bed days needed, and increasing day-case and operating theatre capacity.</p>
<p>There is currently no national tariff for providing XprESS in an outpatient setting. Commissioners are encouraged to work with provider organisations to develop a local tariff.&nbsp;</p>
</td>
<td>
<p><a class="track-link" href="/guidance/mtg30/resources/resource-impact-report-pdf-2731291453" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/mtg30/resources/resource-impact-report-pdf-2731291453"> <i class="icon-download"></i> Resource impact report </a></p>
<p><a class="track-link" href="/guidance/mtg30/resources/resource-impact-template-excel-2731290157" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/mtg30/resources/resource-impact-template-excel-2731290157"> <i class="icon-download"></i> Resource impact template </a></p>
</td>
<td class="xl72" width="85" style="text-align: right;"><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">&pound;13,600</span></span></td>
<td class="xl72" width="85" style="text-align: right;">&pound;7.4m<span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;"></span></span></td>
</tr>
<tr height="136">
<td class="xl69" width="197"><a href="/dg23">PIGF-based testing to help diagnose suspected pre-eclampsia (DG23)</a></td>
<td class="xl69" width="446">
<p>Implementation of the guideline may lead to a reduction in bed days and increase available clinical time. Current estimates indicate that national savings of around &pound;7.3 million may be possible in year 5. The savings are not anticipated to be cash releasing.</p>
</td>
<td>
<p><a class="track-link" href="/guidance/dg23/resources/resource-impact-report-pdf-2484433261" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/dg23/resources/resource-impact-report-pdf-2484433261"> <i class="icon-download"></i> Resource impact report </a></p>
<p><a class="track-link" href="/guidance/dg23/resources/resource-impact-template-excel-2484575821" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/dg23/resources/resource-impact-template-excel-2484575821"> <i class="icon-download"></i> Resource impact template </a></p>
</td>
<td class="xl72" width="85" style="text-align: right;"><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">&pound;13,500</span></span></td>
<td class="xl72" width="85" style="text-align: right;"><span>&pound;7.3m</span><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;"></span></span></td>
</tr>
<tr height="136">
<td class="xl69" width="197"><a href="/ng2">Bladder cancer: diagnosis and management (NG2)</a></td>
<td class="xl69" width="446">
<p>Savings are expected to arise from a reduction in the number of people with low risk non-muscle-invasive bladder cancer receiving follow-up cystoscopies in secondary care after 12 months.</p>
</td>
<td>
<p><a class="track-link" href="/guidance/ng2/resources/costing-report-pdf-3780397" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/ng2/resources/costing-report-pdf-3780397"> <i class="icon-download"></i> Costing report </a></p>
<p><a class="track-link" href="/guidance/ng2/resources/costing-template-excel-3781693" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/ng2/resources/costing-template-excel-3781693"> <i class="icon-download"></i> Costing template </a></p>
</td>
<td class="xl72" width="85" style="text-align: right;"><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">&pound;11,500</span></span></td>
<td class="xl72" width="85" style="text-align: right;"><span>&pound;6.1m</span><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;"></span></span></td>
</tr>
<tr height="68">
<td class="xl69" width="197"><a href="/ta294">Macular degeneration (wet age-related) - aflibercept (1st line) [ID519] (TA294)</a></td>
<td class="xl69" width="446">
<p>Aflibercept is associated with fewer treatment and monitoring visits: implementing this guidance is therefore likely to release resources to the NHS. Fewer visits will also reduce the burden on people with wet AMD and their carers in terms of time off work and travel costs.</p>
</td>
<td>
<p><a class="track-link" href="/guidance/ta294/resources/costing-template-excel-426726109" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/ta294/resources/costing-template-excel-426726109"> <i class="icon-download"></i> Costing template </a></p>
</td>
<td class="xl72" width="85" style="text-align: right;"><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">&pound;9,600</span></span></td>
<td class="xl72" width="85" style="text-align: right;"><span>&pound;5.2m</span><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;"></span></span></td>
</tr>
<tr height="68">
<td class="xl69" width="197"><a href="/mtg34"> SecurAcath for securing percutaneous catheters (MTG34)</a></td>
<td class="xl69" width="446">
<p>Resource impact work indicates implementation will be cost saving by avoiding or reducing the need to replace adhesive securement devices for PICCs, and are greater the longer a PICC is in place.</p>
</td>
<td>
<p><a class="track-link" href="https://www.nice.org.uk/guidance/mtg34/resources/resource-impact-report-pdf-4481645725" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/ta294/resources/costing-template-excel-426726109"> <i class="icon-download"></i> Resource impact report </a></p>
<p><a class="track-link" href="https://www.nice.org.uk/guidance/mtg34/resources/resource-impact-template-excel-4481647021" data-track-category="resource download" data-track-action="clicked" data-track-label="https://www.nice.org.uk/guidance/mtg34/resources/resource-impact-template-excel-4481647021"> <i class="icon-download"></i> Resource impact template </a></p>
</td>
<td class="xl72" width="85" style="text-align: right;">
<p>&pound;7,700</p>
</td>
<td class="xl72" width="85" style="text-align: right;">
<p>&pound;4.2m</p>
</td>
</tr>
<tr height="85">
<td class="xl69" width="197"><a href="/dg4">Adjunctive colposcopy technologies for examination of the uterine cervix - DySIS and Niris Imaging System (DG4)</a></td>
<td class="xl69" width="446">
<p><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">Use of Dysis may reduce the number of repeat tests and <g class="gr_ gr_160 gr-alert gr_spell gr_inline_cards gr_run_anim ContextualSpelling ins-del multiReplace" id="160" data-gr-id="160">follow up</g> appointments due to higher sensitivity than conventional colposcopy. </span></span></p>
<p><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">It is anticipated there may be fewer diagnostic biopsies required, giving pathology test savings, <g class="gr_ gr_188 gr-alert gr_gramm gr_inline_cards gr_run_anim Punctuation only-ins replaceWithoutSep" id="188" data-gr-id="188">however</g> the improved sensitivity may lead to an increase in treatment biopsies.</span></span><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;"> </span></span></p>
<p><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">Future years savings may be achieved through avoiding progression to surgical interventions. Use of Dysis will incur capital costs with some on-going maintenance costs.</span></span></p>
</td>
<td>
<p><a class="track-link" href="https://www.nice.org.uk/guidance/dg4/resources/costing-template-excel-193069" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/ta294/resources/costing-template-excel-426726109"> <i class="icon-download"></i> Costing template </a></p>
</td>
<td class="xl72" width="85" style="text-align: right;"><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">&pound;8,000</span></span></td>
<td class="xl72" width="85" style="text-align: right;"><span>&pound;4.0m</span><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;"></span></span></td>
</tr>
<tr height="204">
<td class="xl69" width="197"><a href="/cg65">Hypothermia: prevention and management in adults having surgery (CG65)</a></td>
<td class="xl69" width="446">
<p><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">Implementing the guideline may result in the following benefits and savings: </span></span></p>
<ul>
<li><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">fewer patients becoming hypothermic during surgery</span></span></li>
<li><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">a better experience of care for patients</span></span></li>
<li><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">a reduction in costs from adverse events caused by hypothermia.</span></span></li>
</ul>
</td>
<td>
<p><a class="track-link" href="/guidance/cg65/resources/costing-report-pdf-196796269" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/cg65/resources/costing-report-pdf-196796269"> <i class="icon-download"></i> Costing report </a></p>
<p><a class="track-link" href="/guidance/cg65/resources/costing-template-excel-196797565" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/cg65/resources/costing-template-excel-196797565"> <i class="icon-download"></i> Costing template </a></p>
</td>
<td class="xl70" width="85" style="text-align: right;"><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">&pound;7,400</span></span></td>
<td class="xl70" width="85" style="text-align: right;"><span>&pound;4m</span><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;"></span></span></td>
</tr>
<tr height="68">
<td class="xl69" width="197"><a href="/mtg12">EXOGEN ultrasound bone healing system for long bone fractures with non-union or delayed healing (MTG12)</a></td>
<td class="xl69" width="446"><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">The expected annual savings and resources released from using EXOGEN 4000+ per 100,000 population aged 18 years and over is around &pound;5,700. This arises from reduced need for surgical intervention and the associated hospital resource use.</span></span></td>
<td>
<p><a class="track-link" href="/guidance/mtg12/resources/costing-template-excel-10414621" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/mtg12/resources/costing-template-excel-10414621"> <i class="icon-download"></i> Costing template </a></p>
</td>
<td class="xl70" width="85" style="text-align: right;"><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">&pound;5,700</span></span></td>
<td class="xl70" width="85" style="text-align: right;"><span>&pound;2.9m</span><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;"></span></span></td>
</tr>
<tr height="68">
<td class="xl69" width="197"><a href="/mtg15">Vision Amniotic Leak Detector (ALD) to eliminate amniotic fluid leakage as a cause of vaginal wetness in pregnancy (MTG15)</a></td>
<td class="xl69" width="446">
<p><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">Using the Vision ALD could potentially save between &pound;15 and &pound;24 per women depending on the clinical scenario used. This is mainly a productivity saving resulting from reduced staff time required for administering Vision ALD compared to a speculum test.</span></span></p>
</td>
<td>
<p><a class="track-link" href="/guidance/mtg15/resources/costing-template-excel-10453501" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/mtg15/resources/costing-template-excel-10453501"> <i class="icon-download"></i> Costing template </a></p>
</td>
<td class="xl70" width="85" style="text-align: right;"><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">&pound;4,600</span></span></td>
<td class="xl70" width="85" style="text-align: right;"><span>&pound;2.6m</span><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;"></span></span></td>
</tr>
<tr height="119">
<td class="xl69" width="197"><a href="/mtg29">GreenLight XPS for treating benign prostatic hyperplasia (MTG29)</a></td>
<td class="xl67" width="446">
<p>Savings range from &pound;1.3 million when 36% of procedures with GreenLight XPS are done as day cases, to as much as &pound;3.2 million when 70% are done as day cases. Based on 53% of GreenLight XPS procedures being done as day cases, the guidance is estimated to save the NHS around &pound;2.3 million per year.</p>
</td>
<td>
<p><a class="track-link" href="/guidance/mtg29/resources/resource-impact-report-pdf-2541401533" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/mtg29/resources/resource-impact-report-pdf-2541401533"> <i class="icon-download"></i> Resource impact report </a></p>
<p><a class="track-link" href="/guidance/mtg29/resources/resource-impact-template-excel-2541402829" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/mtg29/resources/resource-impact-template-excel-2541402829"> <i class="icon-download"></i> Resource impact template </a></p>
</td>
<td class="xl70" width="85" style="text-align: right;"><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">&pound;4,200</span></span></td>
<td class="xl70" width="85" style="text-align: right;">&pound;2.3m<span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;"></span></span></td>
</tr>
<tr height="68">
<td class="xl69" width="197"><a href="/dg25">High-throughput non-invasive prenatal testing for fetal RHD genotype (DG25)</a></td>
<td class="xl69" width="446">
<p><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">Resource impact work indicates there may be some savings from offsetting the test cost with avoided unnecessary treatment with anti-D immunoglobulin. </span></span></p>
<p><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">Additional benefits include conserving anti-D immunoglobulin stocks and reducing potential adverse events that can be associated with blood product use. Implementation of the guidance will result in savings to providers.</span></span></p>
</td>
<td>
<p><a class="track-link" href="/guidance/dg25/resources/resource-impact-report-pdf-2675965213" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/dg25/resources/resource-impact-report-pdf-2675965213"> <i class="icon-download"></i> Resource impact report </a></p>
<p><a class="track-link" href="/guidance/dg25/resources/resource-impact-template-excel-2675966509" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/dg25/resources/resource-impact-template-excel-2675966509"> <i class="icon-download"></i> Resource impact template </a></p>
</td>
<td class="xl70" width="85" style="text-align: right;"><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">&pound;690</span></span></td>
<td class="xl70" width="85" style="text-align: right;">&pound;0.4m<span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;"></span></span></td>
</tr>
<tr height="68">
<td class="xl69" width="197"><a href="https://www.nice.org.uk/guidance/dg30/resources">Quantitative faecal immunochemical tests to guide referral for colorectal cancer in primary care (DG30)</a></td>
<td class="xl69" width="446">
<p><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">Faecal immunochemical tests are recommended for routine adoption in primary care to guide referral for suspected colorectal cancer in people who have symptoms but are at low risk. The guidance may lead to savings at a local level from a reduction in the number of colonoscopies performed.</span></span></p>
</td>
<td>
<p><a class="track-link" href="/guidance/dg30/resources/resource-impact-report-pdf-4540427101" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/dg25/resources/resource-impact-report-pdf-2675965213"> <i class="icon-download"></i> Resource impact report </a></p>
<p><a class="track-link" href="/guidance/dg30/resources/resource-impact-template-excel-4540428397" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/dg25/resources/resource-impact-template-excel-2675966509"> <i class="icon-download"></i> Resource impact template </a></p>
</td>
<td class="xl70" width="85" style="text-align: right;"><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">Assess locally</span></span></td>
<td class="xl70" width="85" style="text-align: right;">Assess locally</td>
</tr>
<tr height="68">
<td class="xl69" width="197"><a href="https://www.nice.org.uk/guidance/cg54/resources">Urinary tract infection in under 16s diagnosis and management (CG54)</a></td>
<td class="xl69" width="446">The recommendations on urine testing strategies for infants and children over 3 months and under 3 years have been updated. The savings are dependent on local practice. The estimated annual saving of implementing this guideline for England is anticipated to range from &pound;870,000 to &pound;7.8 million per year.&nbsp;</td>
<td>
<p><a class="track-link" href="/guidance/cg54/resources/resource-impact-report-pdf-4605554989" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/dg25/resources/resource-impact-report-pdf-2675965213"> <i class="icon-download"></i> Resource impact report </a></p>
<p><a class="track-link" href="/guidance/cg54/resources/resource-impact-template-excel-4605553693" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/dg25/resources/resource-impact-template-excel-2675966509"> <i class="icon-download"></i> Resource impact template </a></p>
</td>
<td class="xl70" width="85" style="text-align: right;">Assess locally</td>
<td class="xl70" width="85" style="text-align: right;">Assess locally</td>
</tr>
<tr height="51">
<td class="xl69" width="197"><a href="/mtg33">ENDURALIFE powered CRT-D devices for treating heart failure (MTG33)</a></td>
<td class="xl69" width="446">
<p><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">ENDURALIFE-powered CRT-D devices are expected to be <g class="gr_ gr_146 gr-alert gr_spell gr_inline_cards gr_run_anim ContextualSpelling ins-del multiReplace" id="146" data-gr-id="146">cost saving</g> because they have a long battery life. This means that fewer replacement devices are needed, which reduces exposing patients to an unnecessarily higher risk of complications associated with these replacement procedures.</span></span></p>
</td>
<td>
<p><a class="track-link" href="/guidance/mtg33/resources/resource-impact-report-pdf-4429532269" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/mtg33/resources/resource-impact-report-pdf-4429532269"> <i class="icon-download"></i> Resource impact report </a></p>
<p><a class="track-link" href="/guidance/mtg33/resources/resource-impact-template-excel-4429569853" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/mtg33/resources/resource-impact-template-excel-4429569853"> <i class="icon-download"></i> Resource impact template </a></p>
</td>
<td class="xl70" width="85" style="text-align: right;"><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">Assess locally</span></span></td>
<td class="xl70" width="85" style="text-align: right;"><span>Assess locally</span><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;"></span></span></td>
</tr>
<tr height="51">
<td class="xl69" width="197"><a href="/ng63">Antimicrobial stewardship: changing risk-related behaviours in the general population (NG63)</a></td>
<td class="xl69" width="446"><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">Implementation of the guideline is anticipated to be cost saving with a reduction in the inappropriate prescribing of antimicrobials, an increase in the most appropriate use of antimicrobials, a corresponding reduction in the prevalence of antimicrobial resistance and reduced infections.</span></span></td>
<td>
<p><a class="track-link" href="/guidance/ng63/resources/resource-impact-report-pdf-4359024685" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/ng63/resources/resource-impact-report-pdf-4359024685"> <i class="icon-download"></i> Resource impact report </a></p>
<p><a class="track-link" href="/guidance/ng63/resources/resource-impact-template-excel-4359027277" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/ng63/resources/resource-impact-template-excel-4359027277"> <i class="icon-download"></i> Resource impact template </a></p>
</td>
<td class="xl70" width="85" style="text-align: right;"><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">Assess locally</span></span></td>
<td class="xl70" width="85" style="text-align: right;"><span>Assess locally</span><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;"></span></span></td>
</tr>
<tr height="51">
<td class="xl69" width="197"><a href="/ng57">Physical health of people in prison (NG57)</a></td>
<td class="xl69" width="446">
<p><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">Implementing the recommendation on medicines reconciliation may generate savings for commissioners by reducing costs related to non-elective attendances and prison escort and bed watching. There may need to be some reallocation of resources within prison healthcare to implement this recommendation.</span></span></p>
<p><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">There are a number of recommendations in the guideline where it may be necessary to invest resources to support early interventions and planned management of conditions for people in prison. This investment may lead to savings from reducing emergency incidents and admissions, unplanned treatments, late presentation of conditions, and morbidity and mortality from infectious and communicable diseases.</span></span></p>
</td>
<td>
<p><a class="track-link" href="/guidance/ng57/resources/resource-impact-report-pdf-2674004365" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/ng57/resources/resource-impact-report-pdf-2674004365"> <i class="icon-download"></i> Resource impact report </a></p>
<p><a class="track-link" href="/guidance/ng57/resources/resource-impact-template-excel-2674005661" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/ng57/resources/resource-impact-template-excel-2674005661"> <i class="icon-download"></i> Resource impact template </a></p>
</td>
<td class="xl70" width="85" style="text-align: right;"><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">Assess locally</span></span></td>
<td class="xl70" width="85" style="text-align: right;"><span>Assess locally</span><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;"></span></span></td>
</tr>
<tr height="102">
<td class="xl69" width="197"><a href="/mtg18">The MAGEC system for spinal lengthening in children with scoliosis (MTG18)</a></td>
<td class="xl77" width="446">The insertion costs of MAGEC rods are estimated to be &pound;27,400, with an annual lengthening cost of &pound;900. In contrast, conventional growth rods are estimated to cost &pound;15,300 for insertion and &pound;5,400 for annual lengthening. The additional insertion cost of &pound;12,100 for the MAGEC system has a payback period of less than 3 years. Anticipated savings per child after 6 years are estimated to be around &pound;12,000.</td>
<td>
<p><a class="track-link" href="/guidance/mtg18/resources/costing-statement-pdf-10458685" data-track="resourcedownload" data-track-category="resource download" data-track-action="clicked" data-track-label="/guidance/mtg18/resources/costing-statement-pdf-10458685"> <i class="icon-download"></i> Costing statement </a></p>
</td>
<td class="xl70" width="85" style="text-align: right;"><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;">Assess locally</span></span></td>
<td class="xl70" width="85" style="text-align: right;"><span>Assess locally</span><span face="Lato, Helvetica Neue, Helvetica, Arial, sans-serif" style="font-family: Lato, 'Helvetica Neue', Helvetica, Arial, sans-serif;"><span style="font-size: 16px;"></span></span></td>
</tr>
</tbody>
</table>


</div></div>            </div>
    </div>
<!-- layout -->

<div class="zone zone-footer">

<div class="widget-footer widget-footer widget-html-widget widget">
    <div class="widget-content">
      <footer class="footer-wrapper-new">
<div class="footer">
<div class="container no-left-margin">
<div class="row">
<div class="span3" id="main-nav">
<div class="row">
<div class="span12"><a href="/" class="footer-nicelogo"><i class="logo icon-nice-logo"><span class="logotext">NICE</span></i></a>
<ul class="unstyled main-nav-panel">
<li><a href="/about">About NICE</a></li>
<li><a href="/about/what-we-do/into-practice" title="Communities">Into practice</a></li>
<li><a href="/news">News</a></li>
<li><a href="/get-involved/contact-us">Contact us</a></li>
<li><a href="/leave-feedback">Leave feedback</a></li>
<li><a href="/get-involved/jobs">Jobs</a></li>
</ul>
</div>
</div>
<div class="row">
<div class="span12" id="social">
<ul class="unstyled">
<li><a href="http://www.nice.org.uk/news/nice-newsletters-and-alerts"> <i class="icon-nice-readnews"></i>Newsletters and alerts</a></li>
<li><a href="https://www.nice.org.uk/news/blog"> <i class="icon-nice-user"></i> Blog </a></li>
<li><a href="//twitter.com/NICEcomms?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor"><i class="icon-nice-twitter"></i>Twitter</a></li>
<li><a href="//www.youtube.com/user/NICEmedia"><i class="icon-youtube-play fa"></i>YouTube</a></li>
<li><a href="https://en-gb.facebook.com/NationalInstituteforHealthandCareExcellence/"><i class="icon-nice-facebook"></i>&nbsp; Facebook</a></li>
<li><a href="//www.linkedin.com/company/national-institute-for-health-and-clinical-excellence"><i class="icon-linkedin-sign fa"></i>LinkedIn</a></li>
</ul>
</div>
</div>
</div>
<div class="span3" id="explore">
<h2>Explore</h2>
<ul class="unstyled" id="explore-panel">
<li><a href="/guidance">Guidance</a></li>
<li><a href="//pathways.nice.org.uk">Pathways</a></li>
<li><a href="/standards-and-indicators">Standards and indicators</a></li>
<li><a href="//www.evidence.nhs.uk/">Evidence search</a></li>
<li><a href="https://bnf.nice.org.uk">BNF</a></li>
<li><a href="https://bnfc.nice.org.uk/">BNFC</a></li>
<li><a href="https://cks.nice.org.uk">Clinical knowledge summaries</a></li>
<li><a href="/about/what-we-do/evidence-services/journals-and-databases">Journals and databases</a></li>
</ul>
</div>
<div class="span3" id="syndication">
<h2><a href="/re-using-our-content">Reusing our content</a></h2>
<ul class="unstyled" id="reuse-panel">
<li><a href="/re-using-our-content">Reuse information</a></li>
<li><a href="/re-using-our-content/uk-open-content-licence">NICE UK Open Content Licence</a></li>
</ul>
<br />
<h2>Guidance app</h2>
<div class="row">
<div class="span12">
<ul class="unstyled">
<li><a href="//play.google.com/store/apps/details?id=com.nice.android"><i class="icon-android fa"></i>Android</a></li>
<li><a href="//itunes.apple.com/gb/app/nice-guidance/id505146575?mt=8"><i class="icon-apple fa"></i>iOS</a></li>
</ul>
</div>
</div>
</div>
<div id="get-involved">
<div class="span3">
<h2><a href="/get-involved" title="Get involved">Get involved</a></h2>
<ul class="unstyled" id="get-involved-panel">
<li><a href="/get-involved/stakeholder-registration">Register as a stakeholder</a></li>
<li><a href="/get-involved/citizens-council">Citizens council</a></li>
<li><a href="/get-involved/consultations">Consultations</a></li>
<li><a href="/get-involved/fellows-and-scholars">Fellows and scholars</a></li>
<li><a href="/get-involved/join-a-committee">Join a committee</a></li>
<li><a href="/get-involved/meetings-in-public">Meetings in public</a></li>
<li><a href="/get-involved/student-champions">Student champions</a></li>
<li><a href="/get-involved/tenders">Tenders</a></li>
<li><a href="/about/nice-communities/public-involvement">Public involvement</a></li>
</ul>
</div>
</div>
</div>
</div>
<div class="container line-div  hidden-phone">
<div class="row">
<div class="line"></div>
</div>
</div>
<div class="legal-panel">
<div class="container">
<ul class="nav nav-legal">
<li><a href="/accessibility">Accessibility</a></li>
<li><a href="/freedom-of-information">Freedom of information</a></li>
<li><a href="/about/what-we-do/nice-syndication-api">Syndication services</a></li>
<li><a href="/glossary">Glossary</a></li>
<li><a href="/terms-and-conditions">Terms and conditions</a></li>
<!--<li><a href="/help">Help</a></li>--></ul>
<p class="legal-copyright">&copy; NICE [year]. All rights reserved. Subject to <a href="/terms-and-conditions#notice-of-rights">Notice of rights</a>.</p>
</div>
</div>
</div>
</footer>
<script>// <![CDATA[
var cpy = document.getElementsByClassName("legal-copyright")[0];
cpy.innerHTML = cpy.innerHTML.replace("[year]", new Date().getFullYear());
// ]]></script>
    </div>
  </div></div>
    <script src="//cdn.nice.org.uk/V2/Scripts/twitter.bootstrap.min.js" type="text/javascript"></script>
<script src="//cdn.nice.org.uk/V2/Scripts/NICE.bootstrap.min.js" type="text/javascript"></script>
<script type="text/javascript"></script>
<script src="https://www.nice.org.uk/Modules/Orchard.Resources/scripts/history.min.js" type="text/javascript"></script>
<script src="//cdn.nice.org.uk/V3/Scripts/nice/NICE.EventTracking.js" type="text/javascript"></script>
<script src="https://www.nice.org.uk/Themes/NICE.Bootstrap/scripts/niceorg/NICE.TopScroll.js" type="text/javascript"></script>
<script src="https://www.nice.org.uk/Themes/NICE.Bootstrap/scripts/foot.combined-v1.10.6834.0.js" type="text/javascript"></script>


    <script src="//cdn.nice.org.uk/V3.1/Scripts/nice/NICE.TopHat.min.js"
            data-environment="Live"
            data-search="/search?q=%term"
            data-typeaheadtype="remote"
            data-typeaheadsource="/autocomplete?%query"
                        data-search-placeholder="Search NICE..."
            data-cookie="true"
            async></script>

    <script type="text/javascript">
        $(document).ajaxSend(function (event, jqxhr, settings) {
            if (settings.url.indexOf("?") >= 0) {
                settings.url = settings.url + "&ajax=ajax";
            } else {
                settings.url = settings.url + "?ajax=ajax";
            }
        })
    </script>
    <script type="text/javascript">
        var is_touch_device = 'ontouchstart' in document.documentElement;
        if (is_touch_device) {
            $('body').addClass('touch-screen-device');
        } else {
            $('body').addClass('non-touch-screen-device');
        }
    </script>
</body>

</html>

